Comerica Bank Purchases 715 Shares of HCA Healthcare, Inc. $HCA

Key Points

• Comerica Bank increased its stake in HCA Healthcare by 2.0%, acquiring an additional 715 shares, bringing its total holdings to 36,571 shares valued at approximately $12.6 million.
• HCA Healthcare reported better-than-expected earnings for the quarter with an EPS of $6.84, surpassing analyst expectations of $6.20, and achieved a revenue of $18.61 billion.
• The company announced a quarterly dividend of $0.72 per share, indicating a 0.7% yield, scheduled to be paid on September 30th to shareholders of record by September 16th.

Comerica Bank increased its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 2.0% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 36,571 shares of the company's stock after buying an additional 715 shares during the period. Comerica Bank's holdings in HCA Healthcare were worth $12,637,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the company. Price T Rowe Associates Inc. MD boosted its holdings in shares of HCA Healthcare by 83.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company's stock worth $829,104,000 after buying an additional 1,091,416 shares during the period. Northern Trust Corp boosted its holdings in HCA Healthcare by 12.4% in the 4th quarter. Northern Trust Corp now owns 2,017,971 shares of the company's stock valued at $605,694,000 after purchasing an additional 223,248 shares during the period. Nuveen Asset Management LLC boosted its holdings in HCA Healthcare by 4.5% in the 4th quarter. Nuveen Asset Management LLC now owns 1,865,771 shares of the company's stock valued at $560,011,000 after purchasing an additional 81,105 shares during the period. Goldman Sachs Group Inc. boosted its holdings in HCA Healthcare by 49.1% in the 1st quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company's stock valued at $615,583,000 after purchasing an additional 587,036 shares during the period. Finally, GAMMA Investing LLC boosted its holdings in HCA Healthcare by 40,527.3% in the 1st quarter. GAMMA Investing LLC now owns 1,703,907 shares of the company's stock valued at $5,887,850,000 after purchasing an additional 1,699,713 shares during the period. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Trading Down 0.3%

Shares of HCA Healthcare stock opened at $401.72 on Wednesday. The stock has a market capitalization of $94.00 billion, a P/E ratio of 16.89, a price-to-earnings-growth ratio of 1.27 and a beta of 1.39. The company has a quick ratio of 0.86, a current ratio of 0.98 and a debt-to-equity ratio of 69.07. The company has a 50-day simple moving average of $375.19 and a 200 day simple moving average of $355.12. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. The business had revenue of $18.61 billion during the quarter, compared to analysts' expectations of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The firm's revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter last year, the company posted $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be given a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.7%. The ex-dividend date is Tuesday, September 16th. HCA Healthcare's dividend payout ratio (DPR) is presently 12.11%.

Analyst Ratings Changes

A number of brokerages have weighed in on HCA. Truist Financial increased their price target on shares of HCA Healthcare from $390.00 to $415.00 and gave the company a "buy" rating in a report on Wednesday, July 16th. Wolfe Research cut shares of HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research note on Monday, July 28th. Stephens upgraded shares of HCA Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Wall Street Zen upgraded shares of HCA Healthcare from a "hold" rating to a "buy" rating in a research note on Saturday, July 5th. Finally, Robert W. Baird increased their price objective on shares of HCA Healthcare from $380.00 to $423.00 and gave the company a "neutral" rating in a research note on Thursday, August 14th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and nine have given a Hold rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $401.83.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.